0001144204-16-133782.txt : 20161114 0001144204-16-133782.hdr.sgml : 20161111 20161114100016 ACCESSION NUMBER: 0001144204-16-133782 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161114 DATE AS OF CHANGE: 20161114 EFFECTIVENESS DATE: 20161114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Foresite Capital Management II, LLC CENTRAL INDEX KEY: 0001594912 IRS NUMBER: 464028844 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16497 FILM NUMBER: 161991510 BUSINESS ADDRESS: STREET 1: 600 MONTGOMERY STREET STREET 2: SUITE 4500 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 600 MONTGOMERY STREET STREET 2: SUITE 4500 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001594912 XXXXXXXX 09-30-2016 09-30-2016 false Foresite Capital Management II, LLC

600 Montgomery Street Suite 4500 San Francisco CA 94111

13F HOLDINGS REPORT 028-16497 N James B. Tananbaum 415-877-4887 /s/ James B. Tananbaum San Francisco CA 11-11-2016 0 10 209419 INFORMATION TABLE 2 infotable.xml Aerie Pharmaceuticals, Inc. COM 00771V108 63128 1672714 SH SOLE 1672714 0 0 Aimmune Therapeutics, Inc. COM 00900T107 59519 3967900 SH SOLE 3967900 0 0 Alder Biopharmaceuticals Inc. COM 014339105 26305 802724 SH SOLE 802724 0 0 BioDelivery Sciences International, Inc. COM 09060J106 608 225281 SH SOLE 225281 0 0 Epizyme, Inc. COM 29428V104 15184 1543118 SH SOLE 1543118 0 0 NanoString Technologies, Inc. COM 63009R109 15042 752857 SH SOLE 752857 0 0 Nexvet Biopharma public limited company ORD SHS G6503X109 3736 900155 SH SOLE 900155 0 0 Orexigen Therapeutics, Inc. COM 686164104 1802 542755 SH SOLE 542755 0 0 Universal American Corp. COM 91338E101 21579 2820791 SH SOLE 2820791 0 0 Zafgen, Inc. COM 98885E103 2516 760046 SH SOLE 760046 0 0